ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,356 | -99.8% | 400,000 | 0.0% | 0.13% | +140.0% |
| Q3 2022 | $1,280,000 | -28.6% | 400,000 | 0.0% | 0.06% | -42.7% |
| Q2 2022 | $1,792,000 | -16.1% | 400,000 | 0.0% | 0.10% | +7.9% |
| Q1 2022 | $2,136,000 | -63.7% | 400,000 | 0.0% | 0.09% | -44.4% |
| Q4 2021 | $5,880,000 | -29.7% | 400,000 | 0.0% | 0.16% | -14.4% |
| Q3 2021 | $8,364,000 | +18.2% | 400,000 | 0.0% | 0.19% | +29.9% |
| Q2 2021 | $7,076,000 | +188.8% | 400,000 | +300.0% | 0.14% | +234.9% |
| Q1 2021 | $2,450,000 | -27.6% | 100,000 | 0.0% | 0.04% | -41.1% |
| Q4 2020 | $3,385,000 | -5.0% | 100,000 | -29.8% | 0.07% | -16.1% |
| Q3 2020 | $3,564,000 | -29.6% | 142,500 | -5.0% | 0.09% | -38.7% |
| Q2 2020 | $5,060,000 | – | 150,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |